Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus. Merrill JT, Werth VP, Furie R, van Vollenhoven R, et al. N Engl J Med 2022;386:1034-1045.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Merrill JT, Werth VP, Furie R, van Vollenhoven R, et al. Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus. N Engl J Med 2022;386:1034-1045.
PMID: 35294813